市場調査レポート

持続的血糖モニタリングの世界市場 - Guardian Real Time、FreeStyle Navigator、Dexcom Seven Plus、Dexcom G4 Platinum、MiniMed Paradigm Revel/Veo持続的血糖モニタリングシステムほか - 産業分析、規模、シェア、成長率、動向および予測

Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 296696
出版日 ページ情報 英文 68 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
持続的血糖モニタリングの世界市場 - Guardian Real Time、FreeStyle Navigator、Dexcom Seven Plus、Dexcom G4 Platinum、MiniMed Paradigm Revel/Veo持続的血糖モニタリングシステムほか - 産業分析、規模、シェア、成長率、動向および予測 Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2014年02月24日 ページ情報: 英文 68 Pages
概要

当レポートでは、Guardian Real Time、FreeStyle Navigator、Dexcom Seven Plus、Dexcom G4 Platinum、MiniMed Paradigm Revel/Veoなど持続的血糖モニタリングシステム(CGM)の製品市場に注目し、新製品発売、売上額、地域別勢力図、利用度、技術開発、競合環境などのファクターを分析・検証しながら、将来発展の推移を世界的視点から予測するほか、主要各企業のプロフィールをまとめ、概略以下の構成でお届けします。

第1章 序

  • レポートの内容説明
  • 市場セグメンテーション
  • 調査方法
    • 情報源
      • 二次調査(情報検索など)
      • 一次調査(直接取材)
    • 前提

第2章 エグゼクティブサマリー

  • 市場寸見:持続的血糖モニタリングの世界市場
  • 持続的血糖モニタリングの世界市場 - 装置・ブランド別(単位:100万米ドル)

第3章 市場概要

  • 概要
  • 市場推進要因
    • 糖尿病人口の世界的増加
    • ポイントオブケア検査(POCT)需要の拡大
  • 市場抑制要因
    • 不利な医療報酬制度
    • キャリブレーション問題
  • 市場機会
    • 無侵襲技術を基本にした持続的血糖モニタリング装置の開発
  • Portweのファイブフォース分析 - 持続的血糖モニタリングの世界市場
  • 市場求心力分析:持続的血糖モニタリングの世界市場 - 地域別

第4章 持続的血糖モニタリング(GCM)の世界市場 - 装置・ブランド別(単位:100万米ドル)

  • 概要
  • Guardian Real Time CGM System
  • FreeStyle Navigator
  • Dexcom Seven Plus CGM System
  • Dexcom G4 Platinum
  • MiniMed Paradigm Revel/Veo System
  • その他

第5章 持続的血糖モニタリングの世界市場収益 - 地域別(単位:100万米ドル)

  • 概要
  • 北米
  • 欧州
  • アジア太平洋州
  • その他の地域

第6章 競合環境

  • 主要企業別市場シェア分析:持続的血糖モニタリングの世界市場

第7章 提言

  • アジア太平洋州、中南米、中東・アフリカの新興市場重視
  • 付加的利点を持つ先進技術製品への研究開発投資
  • 価格管理への注力

第8章 企業プロフィール(企業概要、財務概要、製品ポートフォリオ、事業戦略、最近の展開)

  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • GlySens Incorporated
  • Insulet Corporation
  • Medtronic, Inc.
  • Nova Biomedical Corporation
  • Senseonics, Incorporated

図表一覧

目次

This report studies the current scenario as well as the future market potential for continuous glucose monitoring systems (CGMS) globally. The market for these CGMS has been segmented by major devices/brands, namely, Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System and others. The market for these systems has been extensively analyzed on the basis of factors such as their commercial launch, sales revenue, geographic presence, usage and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2013 to 2019.

Geographically, the continuous glucose monitoring market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis.

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global continuous glucose monitoring market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market shares. The report concludes with the profiles of major players in the global continuous glucose monitoring market such as Medtronic, Inc., Dexcom, Inc., Abbott Laboratories, Inc., Bayer AG, Nova Biomedical Corporation, Senseonics, Incorporated, GlySens, Incorporated and Insulet Corporation.

The global continuous glucose monitoring market is segmented as follows:

Continuous Glucose Monitoring Market, by Device/Brand

  • Guardian Real Time CGM System
  • FreeStyle Navigator
  • Dexcom Seven Plus CGM System
  • Dexcom G4 Platinum
  • MiniMed Paradigm Revel/Veo System
  • Others

Continuous Glucose Monitoring Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
      • 1.3.1.1 Secondary Research
      • 1.3.1.2 Primary Research
    • 1.3.2 Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
  • 2.2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Market Drivers
    • 3.2.1 Rise in diabetic population globally
    • 3.2.2 Rise in demand for point of care testing (POCT)
  • 3.3 Market Restraints
    • 3.3.1 Unfavourable reimbursement policies
    • 3.3.2 Calibration issues
  • 3.4 Market Opportunities
    • 3.4.1 Development of continuous glucose monitoring devices based on non-invasive techniques
  • 3.5 Porter's Five Forces Analysis for the Global Continuous Glucose Monitoring Market
    • 3.5.1 Bargaining power of suppliers
    • 3.5.2 Bargaining power of buyers
    • 3.5.3 Threat of substitutes
    • 3.5.4 Threat of new entrants
    • 3.5.5 Competitive Rivalry
  • 3.6 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography

Chapter 4 Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 - 2019 (USD Million)

  • 4.1 Overview
    • 4.1.1 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 - 2019 (USD Million)
  • 4.2 Guardian Real Time CGM System
    • 4.2.1 Global Guardian Real Time CGM System Market, 2011 - 2019 (USD Million)
  • 4.3 FreeStyle Navigator
    • 4.3.1 Global FreeStyle Navigator Market, 2011 - 2019 (USD Million)
  • 4.4 Dexcom Seven Plus CGM System
    • 4.4.1 Global Dexcom Seven Plus CGM System Market, 2011 - 2019 (USD Million)
  • 4.5 Dexcom G4 Platinum
    • 4.5.1 Global Dexcom G4 Platinum Market, 2011 - 2019 (USD Million)
  • 4.6 MiniMed Paradigm Revel/Veo System
    • 4.6.1 Global MiniMed Paradigm Revel/Veo System Market, 2011 - 2019 (USD Million)
  • 4.7 Others
    • 4.7.1 Global Other CGM Systems Market, 2011 - 2019 (USD Million)

Chapter 5 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)

  • 5.1 Overview
    • 5.1.1 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)
    • 5.1.2 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
  • 5.2 North America
    • 5.2.1 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • 5.4 Asia-Pacific
    • 5.4.1 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 Rest of the World (RoW) Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Market Share Analysis by Key Players: Global Continuous Glucose Monitoring Market
    • 6.1.1 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations

  • 7.1 Focus on emerging economies of Asia-Pacific, Latin America, Middle East and Africa
  • 7.2 Investing in research and development of technologically advanced products with added benefits
  • 7.3 Emphasis on price control

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Bayer AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 Dexcom, Inc.
    • 8.3.1 Company overview
    • 8.3.2 Financial overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 GlySens Incorporated
    • 8.4.1 Company overview
    • 8.4.2 Product Portfolio
    • 8.4.3 Business Strategies
  • 8.5 Insulet Corporation
    • 8.5.1 Company overview
    • 8.5.2 Financial overview
    • 8.5.3 Product portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 Medtronic, Inc.
    • 8.6.1 Business Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Development
  • 8.7 Nova Biomedical Corporation
    • 8.7.1 Company overview
    • 8.7.2 Product portfolio
    • 8.7.3 Business Strategies
    • 8.7.4 Recent Developments
  • 8.8 Senseonics, Incorporated
    • 8.8.1 Company overview
    • 8.8.2 Product portfolio
    • 8.8.3 Business Strategies
    • 8.8.4 Recent Developments

List of Figures

  • FIG. 1 Continuous Glucose Monitoring: Market Segmentation
  • FIG. 2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
  • FIG. 3 Porter's Five Force Analysis: Global Continuous Glucose Monitoring Market
  • FIG. 4 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
  • FIG. 5 Global Guardian Real Time CGM System Market, 2011 - 2019 (USD Million)
  • FIG. 6 Global FreeStyle Navigator Market, 2011 - 2019 (USD Million)
  • FIG. 7 Global Dexcom Seven Plus CGM System Market, 2011 - 2019 (USD Million)
  • FIG. 8 Global Dexcom G4 Platinum Market, 2011 - 2019 (USD Million)
  • FIG. 9 Global MiniMed Paradigm Revel/Veo System Market, 2011 - 2019 (USD Million)
  • FIG. 10 Global Other CGM Systems Market, 2011 - 2019 (USD Million)
  • FIG. 11 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
  • FIG. 12 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15 RoW Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
  • FIG. 17 Annual Revenue: Abbott Laboratories, Inc., 2010 - 2012 (USD Million)
  • FIG. 18 Annual Revenue: Bayer AG., 2010 - 2012 (USD Million)
  • FIG. 19 Annual Revenue: Dexcom, Inc., 2010 - 2012 (USD Million)
  • FIG. 20 Annual Revenue: Insulet Corporation, 2010 - 2012 (USD Million)
  • FIG. 21 Annual Revenue: Medtronic, Inc., 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
  • TABLE 2 Number of People with Diabetes (20-79 years), by Country/Territory, 2013 (Millions)
  • TABLE 3 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 - 2019 (USD Million)
  • TABLE 4 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top